Sabra Healthcare Reit (SBRA) has disclosed a new risk, in the Regulation category.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sabra Healthcare REIT has reported that there have been no material changes in their assessment of risk factors as outlined in their 2024 Annual Report on Form 10-K. This suggests that the company perceives its risk environment to be stable, with no new significant threats identified. Investors and stakeholders should consider this stability in risk assessment when evaluating the company’s future performance. However, it remains crucial to monitor any potential developments that could alter this risk landscape.
The average SBRA stock price target is $19.40, implying 6.71% upside potential.
To learn more about Sabra Healthcare Reit’s risk factors, click here.